FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)
Links shared publicly online about this topic.
- 1,974total visits
FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)
FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)
View full resource at drugs.com
Tags: Asthma, Asthma Medication, FDA, Singulair
Most Recently Shared on June 13, 2009 at 1:40 am By:
FDA Alert - Leukotriene Inhibitors for Asthma Get 'Precaution' Labeling for Possible Neuropsychiatric Events - http://bit.ly/9q3LW
FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)
drugs.com — “FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)” View full resource at drugs.com
Most Recently Shared on August 29, 2009 at 7:07 pm By:
FDA Alert - Update on Leukotriene Inhibitors: Precaution Labeling for Possible Neuropsychiatric Events - http://bit.ly/SjR6o
Advertisement
